Abstract
Mammalian cells contain an intron-less myc gene, such as the rat s-myc gene and human myc L2 gene, which are expressed in rat embryo chondrocytes and human testis, respectively. Our recent findings demonstrated that s-Myc expression suppresses the growth activity and tumorigenicity of glioma cells, indicating that s-Myc acts as a negative regulator in tumor growth. In addition, we found that s-Myc overexpression can effectively induce apoptotic cell death in human and rat glioma cells without serum deprivation, which is distinct from c-Myc-mediated apoptosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aeschlimann D, Wetterwald A, Fleisch H, Paulsson M (1993) Expression of tissue transglutaminase in skeletal tissues correlates with events of terminal differentiation of chondrocytes. J Cell Biol 120: 1461–1470
Alnemri ES, Fernandes TF, Haidar S, Croce CM, Litwack G (1992) Involvement of bcl-2 in glucocorticoid-induced apoptosis of human pre-B-leukemias. Cancer Res 52: 491–495
Amati B, Littlewood TD, Evan GI, Land H (1993) The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J 12: 5083–5087
Arends MJ, Wyllie AH (1991) Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol 32: 223–254
Asai A, Miyagi Y, Sugiyama A, Gamanuma M, Hong SI, Takamoto S, Nomura K, Matsutani M, Takakura K, Kuchino Y (1994a) Negative effects of wild-type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells: implication of the tumor suppressor genes for therapy. J Neurooncol 19: 259–268
Asai A, Miyagi Y, Sugiyama A, Nagashima Y, Kanemitsu H, Obinata M, Mishima K, Kuchino Y (1994b) The s-Myc protein having the ability to induce apoptosis is selectively expressed in rat embryo chondrocytes. Oncogene 9: 2345–2352
Askew DS, Ashmun RA, Simmons BC, Cleveland JI (1991) Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6: 1915–1922
Bertrand R, Sarang M, Jenkin J, Kerrigan D, Pommier Y (1991) Differential induction of secondary DNA fragmentation by topoismerase II inhibitors in human tumor cell lines with amplified c-myc expression. Cancer Res 51: 6280–6285
Bissonnette RP, Echeverri F, Mahboubi A, Green DR (1992) Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359: 552–554
Bissonnette RP, MaGahon A, Mahboubi A, Green DR (1994) Functional Myc-Max heterodimer is required for activation-induced apoptosis in T cell hybridomas. J Exp Med 180: 2413–2418
Blackwood EM, Eisenman RN (1991) Max: a helix-loop-helix zipper protein that forms a sequence- specific DNA binding complex with Myc. Science 251: 1211–1217
Blackwood EM, Luscher B, Kretzner L, Eisenman RN (1991) The Myc: Max protein complex and cell growth regulation. Cold Spring Harbor Symp Quant Biol LVI: 109–117
Blackwood EM, Luscher B, Eisenman RN (1992) Myc and Max associate in vivo. Genes Dev 6: 71–80
Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849–851
Cleveland JL, Troppmair J, Packham G, Askew DS, Lloyd P, Gonzalez-Garcia M, Nunez G, Ihle JN, Rapp UR (1994) v-raf suppresses apoptosis and promotes growth of interleukin-3-dependent myeloid cells. Oncogene 9: 2217–2226
Davidoff AN, Mendelow BV (1993) Substituted purines elicit differential cytokinetic, molecular and phenotypic effects in HL-60 cells. Exp Hematol 21: 456–601
Duke RC, Cohen JJ (1986) IL2 addiction. Limphokine Res 5: 289–299
Ellis RE, Yuan J, Horvitz HR (1991) Mechanisms and functions of cell death. Annu Rev Cell Biol 7: 663–698
Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119–128
Facchini LM, Chen S, Penn LJ (1994) Dysfunction of the Myc-induced apoptosis mechanism accompanies c-myc activation in the tumorigenic L929 cell line. Cell Growth Differ 5: 637–646
Fanidi A, Harrington EA, Evan GI (1992) Cooperative interaction between c-myc and bcl-2 protooncogenes. Nature 359: 554–556
Farquharson C, Hesketh JE, Loveridge N (1992) The proto-oncogene c-myc is involved in cell differentiation as well as cell proliferation: studies on growth plate chondrocytes in situ. J Cell Physiol 152: 135–144
Fesus L, Tarcsa E, Kedei N, Autuori F, Piacentini M (1991) Degradation of cells dying by apoptosis leads to accumulation of epsilon (gamma-glutamyl) lysine isodipeptide in culture fluid and blood. FEBS Lett 284: 109–112
Fourel G, Trepo C, Bougueleret L, Henglein B, Ponzetto A, Tiollais P, Buendia MA (1990) Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumors. Nature 347: 294–298
Gorman CM, Moffat LF, Howard BH (1982) Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 2: 1044–1051
Gu W, Bhatia K, Magrath IT, Dang CV, Dalla-Favera R (1994) Binding and suppression of the Myc transcriptional activation domain by p107. Science 264: 251–254
Hermeking H, Eick D (1994) Mediation of c-Myc-induced apoptosis by p53. Science 265: 2091–2093
Hoang AT, Cohen KJ, Barrett JF, Bergstorm DA, Dang CV (1994) Participation of cyclin A in Myc-induced apoptosis. Proc Natl Acad Sci USA 91: 6875–6879
Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334–336
Ivanov X, Mladenov Z, Nedyalkov S, Todorov TG, Yakimov M (1964) Experimental investigations into avain leukoses. V. Transmission, haematology and morphology of avian myelocytomatosis. Bull Inst Pathol Comp Anim 10: 5–38
Johnson RS, Spiegelman BM, Papaioannou V (1992) Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell 71: 577–586
Kitanaka C, Sugiyama A, Kanazu S, Miyagi Y, Mishima K, Asai A, Kuchino Y (1995) s-Myc acts as a transcriptional activator and its sequence-specific DNA binding is required for induction of programmed cell death in glioma cells. Cell Death Differ 2: 123–131
Klefstrom J, Vastrik I, Saksela E, Valle J, Eilers M, Alitalo K (1994) c-Myc induces cellular susceptibility to the cytotoxic action of TNF-alpha. EMBO J 13: 5442–5450
Kretzner L, Blackwood EM, Eisenman RN (1992) Myc and Max proteins possess distinct transcriptional activities. Nature 359: 426–429
Kuchino Y, Sugiyama A, Miyagi Y (1990) s-Myc, a new member of the myc family has tumor suppressing activity. Yokohama Med Bull 41: 71–74
Lotem J, Sachs L (1993) Regulation by bcl-2, c-myc and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells. Cell Growth Differ 4: 41–47
Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T (1993) p53 is required for radiation- induced apoptosis in mouse thymocytes. Nature 362: 847–849
Luscher B, Eisenman RN (1990) c-myc and c-myb protein degradation: effect of metabolic inhibitors and heat shock. Mol Cell Biol 8: 2504–2512
Malde P, Collins MK (1994) Disregulation of Myc expression in murine bone marrow cells results in an inability to proliferate in sub-optimal growth factor and an increased sensitivity to DNA damage. Int Immunol 6: 1169–1176
Marvel J, Perkins GR, Lopez RA, Collins MK (1994) Growth factor starvation of bcl-2 overexpressing murine bone marrow cells induced refractoriness to IL-3 stimulation of proliferation. Oncogene 9: 1117–1122
Marx J (1993) Cell death studies yield cancer clues. Science 259: 760–761
Meek DW, Street AJ (1992) Nuclear protein phosphorylation and growth control. Biochem J 287: 1–15
Oren M (1992) The involvement of oncogenes and tumor suppressor genes in the control of apoptosis. Cancer Meta Rev 11: 141–148
Oritani K, Kaisho T, Nakajima K, Hirano T (1992) Retinoic acid inhibits interleukin-6-induced macrophage differentiation and apoptosis in murine hematopoietic cell line, Y6. Blood 80: 2298–2305
Owens GP, Cohen JJ (1992) Identification of genes involved in programmed cell death. Cancer Meta Rev 11: 149–156
Packham G, Cleveland JL (1994) Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis. Mol Cell Biol 14: 5741–5747
Pallavicini MG, Rosette C, Reitsma M, Deteresa PS, Gray LW (1990) Relationship of c-myc gene copy number and gene expression: cellular effects of elevated c-myc protein. J Cell Physiol 143: 372–380
Parkin N, Darveau A, Nicholson R, Sonenberg N (1988) cis-Acting translational effects of the 5′ noncoding region of c-myc mRNA. Mol Cell Biol 8: 2875–2883
Penn LJZ, Laufer EM, Land H (1990) c-myc: evidence for multiple regulatory functions. Semin Cancer Biol 1: 68–87
Prendergast GC, Lawe D, Ziff EB (1991) Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and Ras cotransformation. Cell 65: 395–407
Raff MC. (1992) Social controls on cell survival and cell death. Nature 356: 397–400
Reynolds JE, Yang T, Qian L, Jenkinson JD, Zhou P, Eastman A, Craig RW (1994) Mcl-1, a member of the Bcl-2 family, delays apoptosis induced by c-Myc overexpression in Chinese hamster ovary cells. Cancer Res 54: 6348–6352
Schwab M (1988) The myc-box oncogenes. In: Reddy EP, Skalka AM, Curran T (eds) The oncogene handbook. Elsevier, New York, pp 381–391
Schwartz LM, Smith SW, Jones MEE, Osborne BA (1993) Do all programmed cell death occur via apoptosis? Proc Natl Acad Sci USA 90: 980–984
Selvakumaran M, Lin HK, Sjin RT, Reed JC, Liebermann DA, Hoffman B (1994) The novel primary response gene MyD118 and the protooncogenes myb, myc, and bcl-2 modulate transforming growth factor beta 1-induced apoptosis of myeloid leukemia cells. Mol Cell Biol 14: 2352–2360
Shaw P, Bovey R, Tardy S, Sahli R, Sordat B, Costa J (1992) Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci USA 89: 4495–4499
Sheiness D, Fanshier L, Bishop JM (1978) Identification of nucleotide sequences which may encode the oncogenic capacity of avian retrovirus MC29. J Virol 28: 600–610
Shi Y, Glynn JM, Guilbert LJ, Cotter TG, Bissonnette RP, Green DR (1992) Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 257: 212–214
Shrivastava A, Saleque S, Kalpana GV, Artandi S, Goff SP, Calame K (1993) Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc. Science 262: 1889–1892
Smeyne RJ, Vendrell M, Hayward M, Baker SJ, Miao GG, Schilling K, Robertson LM, Curran T, Morgan JI (1993) Continuous c-fos expression precedes programmed cell death in vivo. Nature 363: 166–169
Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA, el-Houseini ME (1994) Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9: 3389–3396
Stone J, Lange T, Ramsay G, Jakobovits E, Bishop JM, Varmus HE, Lee W (1987) Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol Cell Biol 7: 1697–1709
Strasser A, Harris AW, Bath ML, Cory S (1990) Novel primitive lymphoid tumors induced in transgenic mice by cooperation between myc and bcl-2. Nature 348: 331–333
Sugiyama A, Kume A, Nemoto K, Lee SY, Asami Y, Nemoto F, Nishimura S, Kuchino Y (1989) Isolation and characterization of s-myc, a member of rat myc gene family. Proc Natl Acad Sci USA 86: 9144–9189
Tepper CG, Studzinski GP (1992) Teniposide induces nuclear but not mitochondrial DNA degradation. Cancer Res 52: 3384–3390
Thulasi R, Harbour DV, Thompson EB (1993) Suppression of c-myc is a critical step in glucocorticoid-induced human leukemic cell lysis. J Biol Chem 268: 18306–18312
Tsujimoto Y, Finger L, Yunis J, Nowell P, Croce C (1984) Involvement of the bcl-2 gene in human follicular lymphoma. Science 226: 1097–1099
Vaux DL (1993) Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci USA 90: 786–789
Vaux DL, Weissman IL (1993) Neither macromolecular synthesis nor myc is required for cell death via the mechanism that can be controlled by Bcl-2. Mol Cell Biol 13: 7000–7005
Vaux DL, Cory S, Adams JM (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335: 440–442
Wagner AJ, Small MB, Hay N (1993) Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2. Mol Cell Biol 13: 2432–2440
Wagner AJ, Kokontis JM, Hay N (1994) Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21wafl/cipl. Gene Dev 8: 2817–2830
Williams GT (1991) Programmed cell death: apoptosis and oncogenesis. Cell 65: 1097–1098
Wu FY, Chang NT, Chen WJ, Juan CC (1993) Vitamin K3-induced cell cycle arrest and apoptotic cell death are accompanied by altered expression of c-fos and c-myc in nasopharyngeal carcinoma cells. Oncogene 8: 2237–2244
Wyllie AH (1992) Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Meta Rev 11: 95–103
Wurm FM, Gwinn KA, Kingston RE (1986) Inducible overproduction of the mouse c-myc protein in mammalian cells. Proc Natl Acad Sci USA 83: 5414–5418
Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M (1991) Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352: 345–347
Yonish-Rouach E, Grunwald D, Wilder S, Kimchi A, May E, Lawrence JJ, May P, Oren M (1993) p53-mediated cell death: relationship to cell cycle control. Mol Cell Biol 13: 1415–1423
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kuchino, Y., Asai, A., Kitanaka, C. (1996). Myc-Mediated Apoptosis. In: Kuchino, Y., Müller, W.E.G. (eds) Apoptosis. Progress in Molecular and Subcellular Biology, vol 16. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79850-4_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-79850-4_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-79852-8
Online ISBN: 978-3-642-79850-4
eBook Packages: Springer Book Archive